Benchmarking and briefings for pharmaceutical companies
Jinfo Blog
7th August 2017
Abstract
Find out what briefings and events Jinfo has in store for organisations in the biopharma area.
Item
If you work in the pharmaceutical field, what does Jinfo's recent benchmarking research offer you?
The analysis of the research we recently launched for our Research Focus, "Benchmark information roles - optimise your structure" illustrates that those pharma companies who took part distinguished themselves from their counterparts in manufacturing and professional services in a number of important ways.
Join us at our August events, during which we'll explain what those differences are.
At the same time, our pharma participants had a number of characteristics in common with other industries. For example, their purchasing and licensing is pressured on both sides by budget reductions as well as fee increases.
When we analysed the inputs from pharma companies gained through our benchmarking research and combined that analysis with our one-on-one consulting work with some of the premier pharma information teams globally, we were able to get a clear view into what the best pharma information teams do to establish, enact and communicate a clear vision for their contributions to the success of their organisations.
Find out what those three key insights are in our August pharma events.
Secure your place at one of our exclusive pharma events
The future of information strategy in the pharma industry demands fresh inspiration. Information managers interviewed for our benchmarking data cited sources like TedTalks, Harvard Business Review and the Pharma Documentation Ring (P-D-R) as great sources of inspiration.
Jinfo is also a source of inspiration, as well as a practical resource for bridging the gap between "great idea" and the practicalities of here and now. If you haven't yet done so, contact us to secure your place at one of the events below.
Content
Join a pharma-focused walkthrough of Jinfo, including a short presentation on our benchmarking research and how you can use it now to lay the groundwork for 2018. We'll also highlight our articles, reports and webinars of interest to organisations in the pharmaceutical sector in areas from specialist content sources to patent databases and our research into discovery solutions.
This event is open to Jinfo customers and prospects: Monday 21st August, 16:00 - 16:30 (BST)
Request more information and register by contacting Catherine Dhanjal, head of content, catherine.dhanjal@jinfo.com
Community
Some of the best insights come from peers. Join us at an upcoming Community session - the BioPharma Roundtable - and experience for yourself the special value of these private, confidential sessions.
This event is open to Jinfo customers at any level of subscription: Wednesday 23rd August, 16:00 - 17:00 (BST)
Request more information and register by contacting Amy Burns, head of community, amy.burns@jinfo.com
Consulting
Jinfo works with a number of pharma companies to consult on department optimisation, strategic planning, and stakeholder engagement. To learn more, contact Robin Neidorf, director of research and head of consulting, robin.neidorf@jinfo.com
- Blog post title: Benchmarking and briefings for pharmaceutical companies
- Link to this page
- View printable version
- Guide to value in the Jinfo Research Focus "Benchmark information roles - optimise your structure"
Tuesday, 4th July 2017
- Benchmarking - how Jinfo goes beyond the broad and basic
Monday, 24th July 2017
Discussing news and AI strategies with the Financial Times
Community session
21st November 2024
2025 strategic planning; evaluating research reports; The Financial Times, news and AI
Blog posting
5th November 2024
November 2024 Update
YouTube video
7th November 2024
- 2025 strategic planning; evaluating research reports; The Financial Times, news and AI
5th November 2024 - All recent Jinfo Subscription content
31st October 2024 - End-user training best practice research
24th October 2024
- Jinfo Community session (TBC) (Community) 11th December 2024
- Discussing news and AI strategies with the Financial Times (Community) 21st November 2024
- Asia-Pacific Community session (Community) 19th November 2024